Per the WHO Classification of Tumours (5th edition), essential criteria for this diagnosis include a diffuse glioma with mitotic activity occurring in a child or young adult, absence of mutations in IDH1/2 and H3 genes, and a confirmatory methylation profile or other key molecular features [1]. The gene discussed is IDH1; the disease is glioma.